TABLE OF CONTENTS

Chronic Myelogenous Leukemia Therapies

CML: Balancing Cost, Quality, and Access

Cost-to-Benefit Comparisons in Pharmacy Decisions Bonnie J. May, RPh, MBA 

Oral Therapy for CML and the Nurse’s Changing Role Lisa Schulmeister, RN, MN, APRN-BC, OCN, FAAN 

Cancer Guidelines and Payer Coverage Decisions Michael N. Baxley, MD, MS, MPH